Status:
WITHDRAWN
A Study of a Lifestyle Program on Recurrent Atrial Fibrillation
Lead Sponsor:
Mayo Clinic
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine the impact of a comprehensive lifestyle intervention, including cardiac rehabilitation, prior to catheter ablation (a procedure to stop abnormal electrical sign...
Eligibility Criteria
Inclusion
- Paroxysmal or persistent atrial fibrillation.
- Planned elective catheter ablation of AF.
Exclusion
- Prior catheter ablation.
- Presence of pacemaker/ICD.
- Longstanding persistent AF.
- Uncontrolled AF (including poor rate control or tachycardia-mediated cardiomyopathy requiring urgent cardioversion/ablation at the clinician's assessment).
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06155357
Start Date
September 1 2024
End Date
August 1 2026
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905